A polyvalent multiepitope protein cross-protects against Vibrio cholerae infection in rabbit colonization and passive protection models
Open Access
- 5 December 2022
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (50)
Abstract
Using epitope- and structure-based multiepitope fusion antigen vaccinology platform, we constructed a polyvalent protein immunogen that presents antigenic domains (epitopes) of Vibrio cholerae toxin-coregulated pilus A, cholera toxin (CT), sialidase, hemolysin A, flagellins (B, C, and D), and peptides mimicking lipopolysaccharide O-antigen on a flagellin B backbone. Mice and rabbits immunized intramuscularly with this polyvalent protein immunogen developed antibodies to all of the virulence factors targeted by the immunogen except lipopolysaccharide. Mouse and rabbit antibodies exhibited functional activities against CT enterotoxicity, CT binding to GM 1 ganglioside, bacterial motility, and in vitro adherence of V. cholerae O1, O139, and non-O1/non-O139 serogroup strains. When challenged orogastrically with V. cholerae O1 El Tor N16961 or a non-O1/non-O139 strain, rabbits IM immunized with the immunogen showed a 2-log (99%) reduction in V. cholerae colonization of small intestines. Moreover, infant rabbits born to the mother immunized with the protein immunogen acquired antibodies passively and were protected from bacterial intestinal colonization (>2-log reduction), severe diarrhea (100%), and mild diarrhea (88%) after infection with V. cholerae O1 El Tor (N16961), O1 classical (O395), O139 (Bengal), or a non-O1/non-O139 strain. This study demonstrated that this polyvalent cholera protein is broadly immunogenic and cross-protective, and an adult rabbit colonization model and an infant rabbit passive protection model fill a gap in preclinical efficacy assessment in cholera vaccine development.Keywords
Funding Information
- UofI, Department of Pathobiology, University of Illinois at Urbana-Champaign (200250-282020-282096)
- HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (R01AI121067-01A1)
This publication has 57 references indexed in Scilit:
- Vibrio cholerae Non-O1, Non-O139 Serogroups and Cholera-like Diarrhea, Kolkata, IndiaEmerging Infectious Diseases, 2013
- Genetic Fusions of Heat-Labile Toxoid (LT) and Heat-Stable Toxin b (STb) of Porcine EnterotoxigenicEscherichia coliElicit Protective Anti-LT and Anti-STb AntibodiesClinical and Vaccine Immunology, 2010
- Genetic Fusions of Heat-Labile (LT) and Heat-Stable (ST) Toxoids of Porcine EnterotoxigenicEscherichia coliElicit Neutralizing Anti-LT and Anti-STa antibodiesInfection and Immunity, 2010
- Sialic Acid Catabolism Confers a Competitive Advantage to Pathogenic Vibrio cholerae in the Mouse IntestineInfection and Immunity, 2009
- Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: Comparison with other mucosal and systemic responsesVaccine, 2009
- Incomplete Correlation of Serum Vibriocidal Antibody Titer with Protection fromVibrio choleraeInfection in Urban BangladeshThe Journal of Infectious Diseases, 2004
- Cell Vacuolation Caused by Vibrio cholerae HemolysinInfection and Immunity, 2001
- Intestinal and systemic immune responses in humans after oral immunization with a bivalent B subunit-O1/O139 whole cell cholera vaccineVaccine, 1996
- Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-upThe Lancet, 1990
- Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans.Journal of Experimental Medicine, 1988